About Oxpro Pharma Private Limited
Data last updated:
Oxpro Pharma Private Limited is a private limited company based in Ranchi, Jharkhand, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 04 June 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Ranchi, under CIN U51909JH2020PTC014366. Its GSTIN is 20AADCO1654N1ZI (Jharkhand).
The company has an authorised share capital of ₹1 Cr and a paid-up capital of ₹1 Cr. It is led by directors including Sanjay Kumar (Whole-Time Director) and Saurabh Vidyarthi (Whole-Time Director).
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at C/O Sanjay Kumar F.N. – B2 2nd Floor Wadhwani Tower Karam Toli Chwok, Ranchi, Jharkhand, India – 834008.
As per the financials filed for FY 2022, the company reported a revenue of ₹21.48 Cr, a growth of 49% compared to the previous year. For the same year it recorded a net profit of ₹6.55 Cr (net margin 30.5%) and EBITDA of ₹9.43 Cr (EBITDA margin 43.9%).
The company has about 80 employees on its provident fund (EPFO) records.
Court records list 1 case involving the company, including 1 filed against it.
For more details, the company can be reached via its website oxpropharma.in.
- EmailLocked
- TelephoneLocked
- Website
- Social MediaLocked
- Registered AddressC/O Sanjay Kumar F.N. – B2 2nd Floor Wadhwani Tower Karam Toli Chwok, Ranchi, Jharkhand, India – 834008
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Oxpro Pharma Private Limited
The main business activity of Oxpro Pharma is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Oxpro Pharma Private Limited FY 2025 filings available
Oxpro Pharma Private Limited reported revenue of ₹21.48 Cr (up 49% YoY) for FY 2022.
Compounded Annual Growth Rate (CAGR) of Oxpro Pharma Private Limited
Revenue rose 49% in the latest year. EBITDA rose 72% in the latest year. All are worked out from the filed statements.
Financial Statement Summary of Oxpro Pharma Private Limited
| Metrics | FY 2021-22 | FY 2020-21 |
|---|---|---|
| Profit and Loss Statement | ||
| Revenue from Operations | ₹21.48 Cr | •••• |
| Other Income | •••• | •••• |
| Total Revenue | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• |
| Employee Benefit Expense | •••• | •••• |
| Finance Costs | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• |
| Other Expenses | •••• | •••• |
| Total Expenses | •••• | •••• |
| EBITDA | ₹9.43 Cr | •••• |
| Profit Before Tax | •••• | •••• |
| Tax Expense | •••• | •••• |
| Net Profit (PAT) | ₹6.55 Cr | •••• |
| Balance Sheet | ||
| Share Capital | •••• | •••• |
| Reserves and Surplus | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• |
| Long-term Borrowings | •••• | •••• |
| Short-term Borrowings | •••• | •••• |
| Trade Payables | •••• | •••• |
| Total Liabilities | •••• | •••• |
| Fixed Assets | •••• | •••• |
| Investments | •••• | •••• |
| Inventories | •••• | •••• |
| Trade Receivables | •••• | •••• |
| Cash and Bank Balance | •••• | •••• |
| Total Assets | •••• | •••• |
Financial Ratios of Oxpro Pharma Private Limited
| Metrics | FY 2021-22 | FY 2020-21 |
|---|---|---|
| Profitability | ||
| EBITDA Margin | 43.9% | •••• |
| Net Profit Margin | 30.5% | •••• |
| Return on Equity (ROE) | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• |
| Liquidity and Debt | ||
| Current Ratio | •••• | •••• |
| Quick Ratio | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• |
| Efficiency and Growth | ||
| Asset Turnover | •••• | •••• |
| Receivable Days | •••• | •••• |
| Payable Days | •••• | •••• |
| Inventory Days | •••• | •••• |
| Revenue Growth | •••• | •••• |
| Net Profit Growth | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Oxpro Pharma are in the company report.
Financial statements from FY 2021
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Oxpro Pharma Private Limited
Oxpro Pharma Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Formulations). Revenue, net profit, margin and growth of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Trikona Pharmaceuticals Private Limited | •••• | •••• | •••• | •••• | 186 | Hyderabad, Telangana, India |
| Matoshree Health Care Private Limited | •••• | •••• | •••• | •••• | - | Mumbai, Maharashtra, India |
| Biophar Lifesciences Private Limited | •••• | •••• | •••• | •••• | - | Chandigarh, India |
| Karnani Pharmaceuticals Pvt Ltd | •••• | •••• | •••• | •••• | 35 | Mumbai, Maharashtra, India |
| Shivek Labs Limited | •••• | •••• | •••• | •••• | - | Chandigarh, India |
| Oxpro Pharma Private Limited this company | •••• | •••• | •••• | •••• | - | Ranchi, Jharkhand, India |
| Vans Pharma Private Limited | •••• | •••• | •••• | •••• | - | Chennai, Tamil Nadu, India |
| Sunrise International Labs Limited | •••• | •••• | •••• | •••• | 68 | Hyderabad, Telangana, India |
| Ratan Medicos Private Limited | •••• | •••• | •••• | •••• | 21 | New Delhi, Delhi, India |
| Ce-Chem Pharmaceuticals Private Limited | •••• | •••• | •••• | •••• | - | Bangalore, Karnataka, India |
| Taxila Welcure Private Limited | •••• | •••• | •••• | •••• | - | New Delhi, Delhi, India |
Peers are the five companies nearest above and the five nearest below Oxpro Pharma by revenue in the Pharma industry (Formulations), from the latest filed financials of each company. Revenue, net profit, margin and growth of each peer are in the company report.
Auditor Details of Oxpro Pharma Private Limited
Oxpro Pharma Private Limited is audited by SINHA & GHELANI for the financial year 2022.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| SINHA & GHELANI | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Oxpro Pharma Private Limited
Oxpro Pharma has 3 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sarita Kumari | Additional Director | 02 Dec 2021 | 4 Years 10 Months | Current |
| Sanjay Kumar Also directs: Oxford CT Scan Centre Private Limited | Whole-Time Director | 04 Jun 2020 | 6 Years 4 Months | Current |
| Saurabh Vidyarthi Also directs: Oxford CT Scan Centre Private Limited | Whole-Time Director | 04 Jun 2020 | 6 Years 4 Months | Current |
Ownership and Shareholding of Oxpro Pharma Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Oxpro Pharma Private Limited
Oxpro Pharma Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Legal Cases of Oxpro Pharma Private Limited
Oxpro Pharma Private Limited has 1 court case on record: 1 filed against it. All case is disposed. Status as checked on 03 Oct 2026.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 1 | 1 | 0 |
Cases on record (1 of 1)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Ranchi, Jharkhand | Criminal complaint | Filed against the company by State of Jharkhand | Disposed |
Full case history
All 1 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Employees and EPFO Compliance at Oxpro Pharma Private Limited
Oxpro Pharma Private Limited has a workforce of 80 employees as of Apr 07, 2024.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Oxpro Pharma Private Limited
Oxpro Pharma Private Limited has 3 board changes on record since 2020: 3 appointments. The latest: Sarita Kumari was appointed as Additional Director on 02 Dec 2021.
Credit Ratings, Litigation & Regulatory Alerts for Oxpro Pharma Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Oxpro Pharma Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Oxpro Pharma Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Oxpro Pharma Private Limited
Oxpro Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 20AADCO1654N1ZI | Jharkhand | Active | 03 Jul 2020 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Oxpro Pharma Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Oxpro Pharma Private Limited
Oxpro Pharma is an active private limited company based in Ranchi, Jharkhand, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 04 June 2020 (6+ years old) and is registered under CIN U51909JH2020PTC014366.
Oxpro Pharma reported revenue of ₹21.48 Cr for FY 2022 (up 49% YoY).
Oxpro Pharma has 3 current directors:
- Sanjay Kumar - Whole-Time Director
- Saurabh Vidyarthi - Whole-Time Director
- Sarita Kumari - Additional Director
Oxpro Pharma reported a net profit of ₹6.55 Cr (net margin 30.5%) and EBITDA of ₹9.43 Cr (EBITDA margin 43.9%) for FY 2022, as per its filed financial statements.
The GSTIN of Oxpro Pharma is 20AADCO1654N1ZI, registered in Jharkhand.
The CIN (Corporate Identification Number) of Oxpro Pharma is U51909JH2020PTC014366. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Oxpro Pharma has 1 court case on record: 1 filed against it.
Oxpro Pharma was incorporated on 04 June 2020, making it 6+ years old. It is registered with the Registrar of Companies, Ranchi.
The peers of Oxpro Pharma by revenue are Trikona Pharmaceuticals Private Limited, Matoshree Health Care Private Limited, Biophar Lifesciences Private Limited, Karnani Pharmaceuticals Pvt Ltd, Shivek Labs Limited and 5 more, all in the Pharma industry (Formulations).
Sarita Kumari was appointed as Additional Director on 02 Dec 2021. Sanjay Kumar was appointed as Whole-Time Director on 04 Jun 2020. Saurabh Vidyarthi was appointed as Whole-Time Director on 04 Jun 2020.
Oxpro Pharma can be reached through the website oxpropharma.in. Its registered office is in Ranchi, Jharkhand, India.